Clinical trial
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
NCT00162760 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00162760 |
|---|---|
| Title | Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide |
| Official title | Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis (IPF) |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 19 |
| Start date | Oct 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Sep 13, 2005 |
| Last update posted | Jun 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: